Estimated annual conversion risk during follow-up among participants without detectable <i>Mtb</i> antigen immune responses at enrolment by <i>Mtb</i> infection status for 60 participants assessed more than once.
Sascha Wilk Michelsen
Bolette Soborg
Lars Jorge Diaz
Soren Tetens Hoff
Else Marie Agger
Anders Koch
Ida Rosenkrands
Jan Wohlfahrt
Mads Melbye
10.1371/journal.pone.0177906.t003
https://plos.figshare.com/articles/dataset/Estimated_annual_conversion_risk_during_follow-up_among_participants_without_detectable_i_Mtb_i_antigen_immune_responses_at_enrolment_by_i_Mtb_i_infection_status_for_60_participants_assessed_more_than_once_/5059390
<p>Estimated annual conversion risk during follow-up among participants without detectable <i>Mtb</i> antigen immune responses at enrolment by <i>Mtb</i> infection status for 60 participants assessed more than once.</p>
2017-06-01 17:35:26
whole-blood antigen stimulation
TB vaccine candidate antigens
source population 65 participants
East Greenlanders
Mtb infection
Mtb infection status
characterise Mtb infection stage
Mtb infection stage
Mycobacterium tuberculosis
15 antigens
TB notification system
PPD
Civil Registration System
immunity
Quantiferon-TB Gold testing
12 non-QFT antigens
interferon gamma measurement